|
|
Volumn 29, Issue 2, 2011, Pages 95-97
|
|
ReNeuron and StemCells get green light for neural stem cell trials.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOTECHNOLOGY;
BRAIN DISEASE;
CLINICAL TRIAL (TOPIC);
DRUG INDUSTRY;
GENETIC ENGINEERING;
HUMAN;
METHODOLOGY;
NEURAL STEM CELL;
NOTE;
PARAPLEGIA;
PHYSIOLOGY;
STEM CELL TRANSPLANTATION;
STROKE;
UNITED KINGDOM;
UNITED STATES;
BIOTECHNOLOGY;
BRAIN DISEASES;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
GENETIC ENGINEERING;
GREAT BRITAIN;
HUMANS;
NEURAL STEM CELLS;
PARAPLEGIA;
STEM CELL TRANSPLANTATION;
STROKE;
UNITED STATES;
|
|
EID: 79957958764
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0211-95 Document Type: Note |
|
Times cited : (63)
|
|
References (0)
|
